Table 2 Efficacy evaluation on Day 28 after PCR correction* Intention-To-Treat Analysis
Efficacy evaluation | AS-SMP 3 days (N = 476) | AS-SMP 24 hours (N = 458) | AL 3 days (N = 450) |
|---|---|---|---|
Possible failure – n (%, 95%CI) | 15(3.2%,1.8–5.1) | 26 (5.7%,3.7–8.2) | 33(7.3%,5.1–10.1) |
ETF – n (%) | 0 | 0 | 1(0.2%) |
LCF – n (%, 95%CI) | 3 (0.6%,0.1–1.8) | 2 (0.4%,0.1–1.6) | 0 |
LPF – n (%) | 0 | 0 | 0 |
ACPR – n (%, 95%CI) | 457 (96.0%,93.8–97.6) | 429(93.7,91.0–95.7%) | 414 (92.0,89.1–94.3%) |